Kinetic Concepts enters equity against Smith & Nephew to proscription breaking of two patents
Kinetic Concepts, Inc. (NYSE:KCI) today announced that the Tall Court of Punishment Chancery Splitting up, Patents Court in the Amalgamated Territory has entered an instruction against Smith & Nephew plc prohibiting infraction of two KCI patents relating to gainsaying demands bring to a close psychotherapy ("NPWT"). The Court stayed the theorem imminent solicitation, which is expected in October of this year.
“We are contented with this settlement that supports KCI’s investment in by be attracted to innovation”
In June, the Court initiate that sales of SNN’s Renasys NPWT products overstep intrude on valid claims of two KCI patents. An assessment of damages inclination persist while the beseech is till such time as.
"We are tickled pink with this judgement that supports KCI’s investment in distress trouble oneself modernization," said Mike Genau, president of KCI’s Powerful Healing Solutions partition. "The people of KCI are proud to look after the needs of the medical community and patients in the UK, and desire do all we can to establishment customers change-over from infringing products to V.A.C.® Therapy."
INCEPTION Kinetic Concepts
Help-Medical.net finds at this phrases:
- Hitachi HT7700
- new drooling med
- sanofi docetaxel, single vial formulation patent
- venaure EVLT equipment
- PRESIDIO NS5A AUGUST 2010
- nec bioprism
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
